Report LibraryAll Reports
Datamonitor Healthcare Oncology: Myelofibrosis Market Spotlight
August 26, 2021
Myelofibrosis is a myeloproliferative neoplasm which can exist as a primary disease known as primary myelofibrosis, or can evolve to post-polycythemia vera (PV) or post-essential thrombocythemia (ET) myelofibrosis from PV or ET. It is characterized by the buildup of scar tissue (fibrosis) in bone marrow, which leads to a reduction in blood cell production.
This Datamonitor Healthcare report contains a Market Spotlight module.
|Indications Covered:||Myelofibrosis (MF)|